Group 1 - cbdMD, Inc. will host a conference call on December 17, 2024, at 4:20 p.m. Eastern Time to discuss its financial results for the fourth quarter and fiscal year 2024 [2][3] - The conference call will provide insights into the company's business progress and financial performance as of September 30, 2024 [2] - The call can be accessed via specific dial-in numbers for USA/Canada and international participants, with a replay option available [3] Group 2 - cbdMD, Inc. is recognized as a leading brand in the hemp-derived cannabidiol (CBD) market, offering a wide range of THC-free and Full Spectrum products [4] - The company's product line includes tinctures, gummies, topicals, capsules, and pet products under the Paw CBD brand, as well as functional mushroom supplements through ATRx Labs [4] - cbdMD emphasizes its commitment to quality and trust, with products produced in the U.S. and a focus on consumer accessibility through various retail outlets [4]
cbdMD, Inc. To Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results